$NCSM

NCS Multistage Holdings, Inc. (NCSM): Results of Operations and Financial Condition

NCS Multistage Holdings, Inc. (NCSM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_963797.htm EXHIBIT 99.1 ex_963797.htm Exhibit 99.1 NCS Multistage Holdings, Inc. 19350 State Highway 249, Suite 600 Houston, Texas 77070  PRESS RELEASE  NCS MULTISTAGE HOLDINGS, INC. ANNOUNCES SECOND QUARTER 2026 RESULTS  Second Quarter Results  ● Total revenues

Original reporting
Published Jul 30, 2026, 8:29 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$NCSM
Bearish
medium confidence
Mentioned
$NCSM
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$NCSMBearishMed
01

Why it matters

Traders can reassess near-term risk around profitability, cash generation, and liquidity headroom, especially with acquisition-related expenses tied to the pending Weatherford combination referenced in the CEO quote.

02

Market read

Q2 results show revenue growth year over year but a swing to net loss, lower adjusted EBITDA, and negative operating/free cash flow for the six-month period, alongside a liquidity snapshot of $31.3M cash.

03

What to watch

Cash flow deterioration is partly tied to a $1.4M deposit related to Canadian tax reassessments and working-capital movements (inventory and timing of payments), which may not persist if collections normalize.

Relevance 7/10Novelty 7/10Timing: after-hours filing on July 30, 2026

Background

This is an SEC Form 8-K with Exhibit 99.1 reporting NCS Multistage Holdings’ second quarter 2026 results and financial condition.

Company-level read

Ticker impact

$NCSMBearishMedium confidence
Context

NCSM reported Q2 2026 revenue of $38.4M, net loss of $(4.6)M, and $31.3M cash plus $7.5M finance-lease debt as of June 30.

Expected impact

Near-term volatility risk, with traders likely focusing on margin pressure, cash burn, and the pending Weatherford combination timeline.

Evidence & confidence

This is a primary 8-K earnings release with concrete P&L and cash/liquidity figures, but no explicit guidance or deal terms are included in the provided excerpt.

Market effects

Signals demand variability in oilfield services (Canada fracturing systems down, U.S. Repeat Precision up) and ongoing integration costs tied to acquisitions.

Canada weakness appears seasonal and consolidation-driven, while U.S. revenue growth offsets part of the decline.

International tracer diagnostics project mix shifted, including fewer higher-margin Middle East projects year over year.

Counterpoint

Despite the net loss, gross margin held at 34% and adjusted gross margin improved to 36%, suggesting cost/mix effects rather than a collapse in unit economics.

Key entities

  • NCS Multistage Holdings, Inc.

    Nasdaq-listed oil and natural gas well construction and completion products and services provider reporting Q2 2026 results.

  • Weatherford

    Referenced as the counterparty in NCS’s pending combination, with acquisition-related professional fees impacting SG&A.

Related articles

$NCSMMed

NCS Multistage Holdings, Inc. Announces Second Quarter 2026 Results

Second Quarter Results Total revenues of $38.4 million, a 5% year-over-year improvement Net loss of $(4.6) million and loss per share of $(1.71), compared to net income of $0.9 million and diluted earnings per share of $0.34 in the same quarter of 2025 Adjusted EBITDA of $1.9 million, compared to $2.2 million in the same quarter of 2025 $31.3 million in cash and $7.5 million of total debt, consisting entirely of finance lease obligations, as of June 30, 2026 HOUSTON, July 30, 2026 (GLOBE...

$LLYHighAI 8/10

Prediction: Eli Lilly Could Be One of the Biggest Winners of the Next Decade. Here’s Why.

Eli Lilly (LLY) reported a 48% revenue increase to $23B last quarter, driven by Mounjaro. Shares rose 78% over the past year. Wall Street's consensus target is $1,310, implying 4% upside, while an independent model targets $1,463. Key catalysts include retatrutide's Q1 2027 regulatory filing and Foundayo's global rollout. Risks include price erosion and competition from Novo Nordisk (NVO).

$MTNMedAI 8/10

MTN Group Ltd (MTNOF) (H1 2026) Earnings Call Highlights: Record EBITDA Margin

MTN Group reported mixed H1 2026 results, with fintech revenue growth below guidance due to regulatory and operational challenges in key markets. Nigeria's service revenue growth was impacted by regulatory directives and higher diesel costs, while South Africa's prepaid voice segment continued to drag. The company expects EBITDA margins to be at the lower end of guidance due to higher energy prices. Impairments and tax contingencies also affected earnings. MTN reaffirmed its medium-term guidance

$FNHighAI 8/10

Fabrinet (FN) Q4 2026 Earnings Call Transcript

Fabrinet reported Q4 2026 revenue of $1.316B, up 45% YoY, with full-year revenue at $4.6B, a 36% increase. Non-GAAP EPS for the year was $14.09. The company is restructuring revenue reporting into three categories: data centers, communications infrastructure, and automotive/industrial/other. Data center revenue grew 68% YoY, while communications infrastructure and automotive/industrial/other grew 40% and 8% YoY, respectively. Fabrinet is expanding manufacturing capacity to meet demand.